Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Gastroenterology
Published in: Indian Journal of Gastroenterology 1/2018

01-01-2018 | LETTER

Letter to the editor in response to: The role of preoperative C-reactive protein and procalcitonin as predictors of post-pancreaticoduodenectomy infective complications: A prospective observational study

Authors: Bernardo Cálamo-Guzmán, Luis De Vinatea-Serrano

Published in: Indian Journal of Gastroenterology | Issue 1/2018

Login to get access

Excerpt

We have read the article of Mansukhani et al. [1] with the title of: “The role of preoperative C-reactive protein and procalcitonin as predictors of post-pancreaticoduodenectomy infective complications: A prospective observational study” and we have some comments to add to the discussion. We agree in the use of preoperative procalcitonin (PCT) and C-reactive protein (CRP) as predictors of post-pancreaticoduodenectomy (PD) infective complications; the results of this study support that this serum tests could help in the prevention of postoperative infections. …
Literature
1.
Mansukhani V, Desai G, Shah R, Jagannath P. The role of preoperative C-reactive protein and procalcitonin as predictors of post pancreaticoduodenectomy infective complications:A prospectiveobservational study. Indian J Gastroenterol. 2017;36:289-95.
2.
Jiménez-Aguilar IA. Aspectos económicos del uso de procalcitonina. Rev Latinoam Patol Clín Med Lab. 2017;63:170–5.
3.
Dominguez-Comesana E, Lopez-Gomez V, Estevez-Fernandez SM, et al. Procalcitonin and C-reactive protein as early indicators of postoperative intra-abdominal infection after surgery for gastrointestinal cancer. Cir Esp. 2014;92:240–6.CrossRefPubMed
4.
Vaziri M, Ehsanipour F, Pazouki A, et al. Evaluation of procalcitonin as a biomarker of diagnosis, severity and postoperative complications in adult patients with acute appendicitis. Med J Islam Repub Iran. 2014;28:50.PubMedPubMedCentral
5.
Bustos BR, Padilla PO. Valor predictivo de la procalcitonina en niños con sospecha de sepsis. Rev Chil Pediatr. 2015;86:331–6.
Metadata
Title
Letter to the editor in response to: The role of preoperative C-reactive protein and procalcitonin as predictors of post-pancreaticoduodenectomy infective complications: A prospective observational study
Authors
Bernardo Cálamo-Guzmán
Luis De Vinatea-Serrano
Publication date
01-01-2018
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 1/2018
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-018-0832-2

Other articles of this Issue 1/2018

Indian Journal of Gastroenterology 1/2018 Go to the issue

Original Article

Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson’s disease in resource constrained setting

Original Article

Live donor liver transplantation for acute liver failure: A single center experience

Original Article

Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury—A single-center experience from southern India

Correction

Correction to: Ayurvedic and herbal medicine-induced liver injury: It is time to wake up and take notice

Editorial

Ayurvedic and herbal medicine-induced liver injury: It is time to wake up and take notice

Case report

PRSS1 (R122H) mutation in an Indian family with low penetrance is associated with pancreatitis phenotype
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits